why choose us

Clinical Trials Search

Showing 15,490 of 132,656 result(s)
The Effect of Virtual Reality on Preoperative Anxiety Before Abdominal Surgery

Status: Active, not recruiting

Condition: Anxiety

Interventions: Interventional

Date: 2023-01-30

Quantitative Assessment of the Efficacy of Sweeps Laser Activation Systems

Status: Completed

Condition: Periapical Periodontitis
Polymerase Chain Reaction
Enterococcus Faecalis Infection

Interventions: Interventional

Date: 2023-01-30

Mini-dose Esketamine-dexmedetomidine Supplemented Analgesia and Long-term Outcomes

Status: Active, not recruiting

Condition: Scoliosis Correction
Postoperative Analgesia
Esketamine
Dexmedetomidine
Chronic

Interventions: Interventional

Date: 2023-01-30

AN OBSERVATIONAL STUDY ON CARDIOVASCULAR INVOLVEMENT IN COVID RECOVERED PATIENTS

Status: Completed

Condition: Gender Discrimination
Cardiac Event
Complication

Interventions: Behavioral: Difference in gender, response to disease, diagnostic test values
Gender difference: Prevalence of disease in male vs female Response

Date: 2023-01-30

Impact of Adalimumab Withdrawal or Continuation on Severity of COVID-19 and Risk of IMID Relapse

Status: Completed

Condition: Inflammatory Bowel Diseases
Rheumatic Disorder

Interventions: Drug: Adalimumab
Adalimumab is a fully human, high-affinity, recombinant anti-tumor necrosis factor (TNF) alpha monoclonal antibody used to treat

Date: 2023-01-30

Atrial Fibrillation: Chronic Beta-blocker Use Versus As-needed Rate Control Guided by Implantable Cardiac Monitor

Status: Completed

Condition: Atrial Fibrillation

Interventions: Patients will stop their daily beta-blocker and take as-needed rate control (beta-blocker or calcium channel blocker) guided by their implantable card

Date: 2023-01-30

Effects of Administration of SCFA in Rheumatoid Arthritis Inadequate Responders

Status: Completed

Condition: Rheumatoid Arthritis

Interventions: Participants will self-administer the oral Short Chain Fatty Acid (SCFA) Butyrate supplement three times daily with meals for up to 2 months.
The

Date: 2023-01-30

A Safety, Tolerability and Pharmacokinetics Study of Topical Ointment YR001 in Adult Healthy Volunteers

Status: Completed

Condition: Atopic Dermatitis

Interventions: Part A: Single topical dose

Date: 2023-01-30

Study of TVB-2640 in Men With Metastatic Castration-Resistant Prostate Cancer

Status: NOT_YET_RECRUITING

Condition: Prostatic Neoplasms, Castration-Resistant

Interventions: TVB- 2640 at 100 mg, 150mg, 200 mg, 250 mg, or 300mg daily, orally; dose determined by BOIN dose escalation per the protocol

Date: 2023-01-30

Counseling for Harm Reduction and Retention in Medication-assisted Treatment - Cherokee Nation

Status: Completed

Condition: Opioid Use Disorder

Interventions: TAU entails medication to support patients' recovery (i.e., the partial opioid agonist, buprenorophine + naloxone; Suboxone gel films), in-p

Date: 2023-01-30